Mass spectrometry-based clinical proteomics: Head-and-neck cancer biomarkers and drug-targets discovery

Mass Spectrometry Reviews

Volumn 29, Issue 6, 2010, Pages 945-961

  Matta, Ajay ^a   Ralhan, Ranju ^a,b,c   Desouza, Leroi V ^a   Siu, K W Michael ^a  

^a YORK UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

biomarker; head and neck cancer; isotope dilution mass spectrometry; oral premalignant lesion; quantitative proteomics

Indexed keywords

BIO-MARKER DISCOVERY; CANCER BIOMARKERS; CANCER MARKERS; CELLULAR PATHWAY; CLINICAL SAMPLES; DISEASE MANAGEMENT; DRUG TARGETS; EARLY DETECTION; HEAD-AND-NECK CANCER; HIGH-THROUGHPUT; HUMAN MALIGNANCIES; ISOTOPE-DILUTION MASS SPECTROMETRY; LOW-ABUNDANCE PROTEINS; MALIGNANT TISSUES; NUMBER OF SAMPLES; ORAL PREMALIGNANT LESION; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN PROFILES; PROTEOMIC TECHNOLOGIES; PROTEOMICS; QUALITATIVE AND QUANTITATIVE ANALYSIS; QUALITY OF LIFE; QUANTITATIVE PROTEOMICS; SUBCELLULAR LOCALIZATIONS; TECHNOLOGY PLATFORMS; THERAPEUTIC STRATEGY; TUMOR TISSUES;

BODY FLUIDS; HISTOLOGY; ISOTOPES; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PROTEINS; TUMORS;

BIOMARKERS;

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ARTICLE; DRUG DELIVERY SYSTEM; HEAD AND NECK TUMOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSTRUMENTATION; MASS SPECTROMETRY; META ANALYSIS (TOPIC); METHODOLOGY; MICRODISSECTION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEAD AND NECK NEOPLASMS; HUMANS; MASS SPECTROMETRY; META-ANALYSIS AS TOPIC; MICRODISSECTION; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 78149447880     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.20296     Document Type: Article

References (126)

1. Aebersold R, Rist B, Gygi SP,. 2009. Quantitative proteome analysis: Methods and applications. Ann NY Acad Sci 919: 33 - 47.
2. Ahram M, Flaig MJ, Gillespie JW, Duray PH, Linehan WM, Ornstein DK, Niu S, Zhao Y, Petricoin EF III, Emmert-Buck MR,. 2003. Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications. Proteomics 3: 413 - 421.
3. Akervall J,. 2005. Gene profiling in squamous cell carcinoma of the head and neck. Cancer Metastasis Rev 24: 87 - 94.
4. Anderson L, Hunter CL,. 2006. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5: 573 - 588.
5. Bai Y, Markham K, Chen F, Weerasekera R, Watts J, Horne P, Wakutani Y, Bagshaw R, Mathews PM, Fraser PE, Westaway D, St George-Hyslop P, Schmitt-Ulms G,. 2008. The in vivo brain interactome of the amyloid precursor protein. Mol Cell Proteomics 7: 15 - 34.
6. Baker H, Patel V, Molinolob AA, Shillitoec JE, Ensleyd JF, Yooe GH, Garcÿaf AM, Myersg JN, El-Naggar AL, Gutkind JS, Hancock WS,. 2005. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol 41: 183 - 199.
7. Banerjee HN, Verma M,. 2006. Use of nanotechnology for the development of novel cancer biomarkers. Expert Rev Mol Diagn 6: 679 - 683.
8. Becker GW,. 2008. Stable isotopic labeling of proteins for quantitative proteomic applications. Brief Funct Genomic Proteomic 7: 371 - 382.
9. Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, Masterson J, Patel S, Cordon-Cardo C, Prystowsky MB, Childs G,. 2005. Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg 131: 10 - 18.
10. Belov ME, Anderson GA, Angell NH, Shen Y, Tolic N, Udseth HR, Smith RD,. 2001. Dynamic range expansion applied to mass spectrometry based on data-dependent selective ion ejection in capillary liquid chromatography fourier transform ion cyclotron resonance for enhanced proteome characterization. Anal Chem 73: 5052 - 5060.
11. Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axéll T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Nair R,. 2007. Management of oral epithelial dysplasia: A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103: 1 - 12.
12. Breuker K, Jin M, Han X, Jiang H, McLafferty FW,. 2008. Top-down identification and characterization of biomolecules by mass spectrometry. J Am Soc Mass Spectrom 19: 1045 - 1053.
13. Brinkman BM, Wong DT,. 2006. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol 18: 228 - 233.
14. Chen J, He QY, Yuen AP, Chiu JF,. 2004. Proteomics of buccal squamous cell carcinoma: The involvement of multiple pathways in tumorigenesis. Proteomics 4: 2465 - 2475.
15. Chen C, Méndez E, Houck J, Fan W, Lohavanichbutr P, Doody D, Yueh B, Futran ND, Upton M, Farwell DG, Schwartz SM, Zhao LP,. 2008. Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17: 2152 - 2162.
16. Cho WC, Cheng CH,. 2007. Oncoproteomics: Current trends and future perspectives. Expert Rev Proteomics 4: 401 - 410.
17. Colby BN, McCaman MW,. 1979. A comparison of calculation procedures for isotope dilution determinations using gas chromatography mass spectrometry. Biomed Mass Spectrom 6: 225 - 230.
18. Com E, Hondermarck H,. 2007. Functional proteomics in oncology: To understand more than to describe. Med Sci (Paris) 1: 27 - 30.
19. Cordero OJ, De Chiara L, Lemos-González Y, Páez de la Cadena M, Rodríguez-Berrocal FJ,. 2008. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer. Anticancer Res 28: 2333 - 2341.
20. Deshpande AM, Wong DT,. 2008. Molecular mechanisms of head and neck cancer. Expert Rev Anticancer Ther 8: 799 - 809.
21. DeSouza L, Diehl G, Rodrigues MJ, Guo J, Romaschin AD, Colgan TJ, Siu KWM,. 2005a. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 4: 377 - 386.
22. DeSouza L, Diehl G, Yang ECC, Guo J, Rodrigues MJ, Romaschin AD, Colgan TJ, Siu KWM,. 2005b. Proteomic analysis of the proliferative and secretory phases of the human endometrium: Protein identification and differential protein expression. Proteomics 5: 270 - 281.
23. DeSouza LV, Grigull J, Ghanny S, Dube V, Romaschin AD, Colgan TJ, Siu KWM,. 2007. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 6: 1170 - 1182.
24. DeSouza LV, Taylor AM, Li W, Minkoff MS, Romaschin AD, Colgan TJ, Siu KW,. 2008. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. J Proteome Res 7: 3525 - 3534.
25. Drake RR, Cazare LH, Semmes OJ, Wadsworth JT,. 2005. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. Expert Rev Mol Diagn 5: 93 - 100.
26. Eng J, McCormack AL, Yates JR,. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 5: 976 - 989.
27. Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, Kraus DH, Patel S, Shaha AR, Wong RJ, Huryn JM, Shah JP, Singh B,. 2009. Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 12: 9 - 11.
28. Evans CR, Jorgenson JW,. 2004. Multidimensional LC-LC and LC-CE for high-resolution separations of biological molecules. Anal Bioanal Chem 378: 1952 - 1961.
29. Faca V, Coram M, Phanstiel D, Glukhova V, Zhang Q, Fitzgibbon M, McIntosh M, Hanash S,. 2006. Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. J Proteome Res 5: 2009 - 2018.
30. Finlay EM, Games DE, Startin JR, Gilbert J,. 1986. Screening, confirmation, and quantification of sulphonamide residues in pig kidney by tandem mass spectrometry of crude extracts. Biomed Environ Mass Spectrom 13: 633 - 639.
31. Fliser D, Wittke S, Mischak H,. 2005. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes. Electrophoresis 26: 2708 - 2716. (Pubitemid 41078981)
32. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP,. 2003. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci USA 100: 6940 - 6945.
33. Gevaert K, Impens F, Ghesquière B, Van Damme P, Lambrechts A, Vandekerckhove J,. 2008. Stable isotopic labeling in proteomics. Proteomics 8: 4873 - 4885.
34. Glish GL, Burinsky DJ,. 2008. Hybrid mass spectrometers for tandem mass spectrometry. J Am Soc Mass Spectrom 19: 161 - 172.
35. Görg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W,. 2000. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21: 1037 - 1053.
36. Görg A, Weiss W, Dunn MJ,. 2004. Current two-dimensional electrophoresis technology for proteomics. Proteomics 4: 3665 - 3685.
37. Guo T, Lee CS, Wang W, DeVoe DL, Balgley BM,. 2006. Capillary separations enabling tissue proteomics-based biomarker discovery. Electrophoresis 27: 3523 - 3532.
38. Gygi SP, Han DKM, Gingras AC, Sonenberg N, Aebersold R,. 1999a. Protein analysis by mass spectrometry and sequence database searching: Tools for cancer research in the post-genomic era. Electrophoresis 20: 310 - 319.
39. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R,. 1999b. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994 - 999.
40. Gygi SP, Rist B, Griffin TJ, Eng J, Aebersold R,. 2002. Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J Proteome Res 1: 47 - 54.
41. Harsha HC, Molina H, Pandey A,. 2008. Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nat Protoc 3: 505 - 516.
42. He QY, Chen J, Kung HF, Yuen AP, Chiu JF,. 2004. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4: 271 - 278.
43. Heck AJ, Krijgsveld J,. 2004. Mass spectrometry-based quantitative proteomics. Expert Rev Proteomics 1: 317 - 326.
44. Herrero M, Ibañez E, Cifuentes A,. 2008. Capillary electrophoresis-electrospray-mass spectrometry in peptide analysis and peptidomics. Electrophoresis 29: 2148 - 2160.
45. Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Graham Cooks R,. 2005. The Orbitrap: A new mass spectrometer. J Mass Spectrom 40: 430 - 443.
46. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT,. 2008. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14: 6246 - 6252.
47. Hu S, Loo JA, Wong DT,. 2007a. Human saliva proteome analysis and disease biomarker discovery. Expert Rev Proteomics 4: 531 - 538.
48. Hu S, Wong DT,. 2007. Oral cancer proteomics. Curr Opin Mol Ther 9: 467 - 476.
49. Hu S, Yen Y, Ann D, Wong DT,. 2007b. Implications of salivary proteomics in drug discovery and development: A focus on cancer drug discovery. Drug Discov Today 12: 911 - 916.
50. Issaq HJ, Veenstra TD,. 2007. The role of electrophoresis in disease biomarker discovery. Electrophoresis 28: 1980 - 1988.
51. Iwadate Y,. 2008. Clinical proteomics in cancer research-promises and limitations of current two-dimensional gel electrophoresis. Curr Med Chem 15: 2393 - 2400.
52. Jain KK,. 2007. Cancer biomarkers: Current issues and future directions. Curr Opin Mol Ther 9: 563 - 571.
53. Jain KK,. 2008a. Recent advances in nanooncology. Technol Cancer Res Treat 7: 1 - 13.
54. Jain MR, Liu T, Hu J, Darfler M, Fitzhugh V, Rinaggio J, Li H,. 2008. Quantitative proteomic analysis of formalin fixed paraffin embedded oral HPV lesions from HIV patients. Open Proteomics J 1: 40 - 45.
55. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. 2008. Cancer statistics, 2008. CA Cancer J Clin 58: 71 - 96.
56. Kato H, Uzawa K, Onda T, Kato Y, Saito K, Nakashima D, Ogawara K, Bukawa H, Yokoe H, Tanzawa H,. 2006. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma. Int J Oncol 28: 873 - 881.
57. Koehn J, Krapfenbauer K, Huber S, Stein E, Sutter W, Watzinger F, Erovic BM, Thurnher D, Schindler T, Fountoulakis M, Turhani D,. 2008. Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. J Proteome Res 7: 3818 - 3829.
58. Koike H, Uzawa K, Nakashima D, Shimada K, Kato Y, Higo M, Kouzu Y, Endo Y, Kasamatsu A, Tanzawa H,. 2005. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 27: 59 - 67.
59. Kolch W, Neusüss C, Pelzing M, Mischak H,. 2005. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev 24: 959 - 977.
60. Kondo T,. 2008. Tissue proteomics for cancer biomarker development: Laser microdissection and 2D-DIGE. BMB Rep 41: 626 - 634.
61. Kruse U, Bantscheff M, Drewes G, Hopf C,. 2008. Chemical and pathway proteomics: Powerful tools for oncology drug discovery and personalized health care. Mol Cell Proteomics 7: 1887 - 1901.
62. Kulasingam V, Diamandis EP,. 2008. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 5: 588 - 599.
63. Li J, Steen H, Gygi SP,. 2003. Protein profiling with cleavable isotope-coded affinity tag (cICAT) reagents. Mol Cell Proteomics 2: 1198 - 1204.
64. Lo WY, Tsai MH, Tsai Y, Hua CH, Tsai FJ, Huang SY, Tsai CH, Lai CC,. 2007a. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 376: 101 - 107.
65. Lo WY, Lai CC, Hua CH, Tsai MH, Huang SY, Tsai CH, Tsai FJ,. 2007b. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J Proteome Res 6: 2143 - 2151.
66. Luna LG, Williams TL, Pirkle JL, Barr JR,. 2008. Ultra performance liquid chromatography isotope dilution tandem mass spectrometry for the absolute quantification of proteins and peptides. Anal Chem 80: 2688 - 2693.
67. Mann M, Wilm M,. 1994. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem 66: 4390 - 4399.
68. Marouga R, David S, Hawkins E,. 2005. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382: 669 - 678.
69. Matta A, DeSouza LV, Shukla NK, Gupta SD, Ralhan R, Siu KW,. 2008. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 7: 2078 - 2087.
70. McLafferty FW, Breuker K, Jin M, Han X, Infusini G, Jiang H, Kong X, Begley TP,. 2007. Top-down MS, a powerful complement to the high capabilities of proteolysis proteomics. FEBS J 274: 6256 - 6268.
71. Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra JP, Dominiczak AF,. 2009. Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments. Mass Spectrom Rev 28: 703 - 724.
72. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS,. 2009. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45: 324 - 334.
73. Mykytluk AP, Russell DS, Sturgeon RE,. 1980. Simultaneous determination of iron, cadmium, zinc, copper, nickel, lead, and uranium in sea water by stable isotope dilution spark source mass spectrometry. Anal Chem 52: 1281 - 1283.
74. Nagaraj NS,. 2009. Evolving omics technologies for diagnostics of head and neck cancer. Brief Funct Genomic Proteomic 1: 49 - 59.
75. Nie S, Xing Y, Kim GJ, Simons JW,. 2007. Nanotechnology applications in cancer. Annu Rev Biomed Eng 9: 257 - 288.
76. Nilsson CL, Davidsson P,. 2000. New separation tools for comprehensive studies of protein expression by mass spectrometry. Mass Spectrom Rev 19: 390 - 397.
77. Onda T, Uzawa K, Nakashima D, Saito K, Iwadate Y, Seki N, Shibahara T, Tanzawa H,. 2007. Lin-7C/VELI3/MALS-3: An essential component in metastasis of human squamous cell carcinoma. Cancer Res 67: 9643 - 9648. (Pubitemid 47621210)
78. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M,. 2002. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376 - 386.
79. Ong SE, Kratchmarova I, Mann M,. 2003. Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). J Proteome Res 2: 173 - 181.
80. Ong SE, Mann M,. 2005. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1: 252 - 262.
81. Ong SE, Mann M,. 2006. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc 1: 2650 - 2660.
82. Ong SE, Mann M,. 2007. Stable isotope labeling by amino acids in cell culture for quantitative proteomics. Methods Mol Biol 359: 37 - 52.
83. Ono M, Shitashige M, Honda K, Isobe T, Kuwabara H, Matsuzuki H, Hirohashi S, Yamada T,. 2006. Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry. Mol Cell Proteomics 5: 1338 - 1347.
84. Pan S, Aebersold R, Chen R, Rush J, Goodlett DR, McIntosh MW, Zhang J, Brentnall TA,. 2009. Mass spectrometry based targeted protein quantification: Methods and applications. J Proteome Res 8: 787 - 797.
85. Parkin DM, Bray F, Ferlay J, Pisani P,. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55: 74 - 108.
86. Pasa-Tolić L, Harkewicz R, Anderson GA, Tolić N, Shen Y, Zhao R, Thrall B, Masselon C, Smith RD,. 2002. Increased proteome coverage for quantitative peptide abundance measurements based upon high performance separations and DREAMS FTICR mass spectrometry. J Am Soc Mass Spectrom 13: 954 - 963.
87. Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS,. 2008. Proteomic analysis of laser-captured paraffin-embedded tissues: A molecular portrait of head and neck cancer progression. Clin Cancer Res 14: 1002 - 1014.
88. Patton LL, Epstein JB, Kerr AR,. 2008. Adjunctive techniques for oral cancer examination and lesion diagnosis: A systematic review of the literature. J Am Dent Assoc 139: 896 - 905.
89. Perry RH, Cooks RG, Noll RJ,. 2008. Orbitrap mass spectrometry: Instrumentation, ion motion and applications. Mass Spectrom Rev 27: 661 - 699.
90. Phan JH, Young AN, Wang MD,. 2006. Selecting clinically-driven biomarkers for cancer nanotechnology. Conf Proc IEEE Eng Med Biol Soc 1: 3317 - 3320.
91. Phillips WH, Jr., Ota K, Wade NA,. 1989. Tandem mass spectrometry (MS/MS) utilizing electron impact ionization and multiple reaction monitoring for the rapid, sensitive, and specific identification and quantification of morphine in whole blood. J Anal Toxicol 13: 349 - 355.
92. Preisinger C, von Kriegsheim A, Matallanas D, Kolch W,. 2008. Proteomics and phosphoproteomics for the mapping of cellular signalling networks. Proteomics 8: 4402 - 4415.
93. Qin J, Fenyö D, Zhao Y, Hall WW, Chao DM, Wilson CJ, Young RA, Chait BT,. 1997. A strategy for rapid, high-confidence protein identification. Anal Chem 69: 3995 - 4001.
94. Ralhan R, DeSouza LV, Matta A, Chandra Tripathi S, Ghanny S, Datta Gupta S, Bahadur S, Siu KW,. 2008. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics 7: 1162 - 1173.
95. Ralhan R, Desouza LV, Matta A, Chandra Tripathi S, Ghanny S, Dattagupta S, Thakar A, Chauhan SS, Siu KW,. 2009. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res 8: 300 - 309.
96. Roesch-Ely M, Nees M, Karsai S, Ruess A, Bogumil R, Warnken U, Schnolzer M, Dietz A, Plinkert PK, Hofele C, Bosch FX,. 2007. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 26: 54 - 64.
97. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S,. 2004. Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154 - 1169.
98. Russo G, Zegar C, Giordano A,. 2003. Advantages and limitations of microarray technology in human cancer. Oncogene 22: 6497 - 6507.
99. Sachon E, Mohammed S, Bache N, Jensen ON,. 2006. Phosphopeptide quantitation using amine-reactive isobaric tagging reagents and tandem mass spectrometry: Application to proteins isolated by gel electrophoresis. Rapid Commun Mass Spectrom 20: 1127 - 1134.
100. Schiffer E, Mischak H, Novak J,. 2006. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics 6: 5615 - 5627.
101. Schleif FM, Villmann T, Kostrzewa M, Hammer B, Gammerman A,. 2009. Cancer informatics by prototype networks in mass spectrometry. Artif Intell Med 45: 215 - 228.
102. Simpson RJ, Bernhard OK, Greening DW, Moritz RL,. 2008. Proteomics-driven cancer biomarker discovery: Looking to the future. Curr Opin Chem Biol 12: 72 - 77.
103. Siu KWM, Bednas ME, Berman SS,. 1983. Determination of chromium in seawater by isotope dilution gas chromatography/mass spectrometry. Anal Chem 55: 473 - 476.
104. Smith AM, Dave S, Nie S, True L, Gao X,. 2006. Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn 6: 231 - 244.
105. Smith IM, Mithani SK, Liu C, Chang SS, Begum S, Dhara M, Westra W, Sidranksy D, Califano JA,. 2009. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development. Arch Otolaryngol Head Neck Surg 135: 487 - 495.
106. Song EJ, Babar SM, Oh E, Hasan MN, Hong HM, Yoo YS,. 2008. CE at the omics level: Towards systems biology-An update. Electrophoresis 29: 129 - 142.
107. Staab CA, Ceder R, Jägerbrink T, Nilsson JA, Roberg K, Jörnvall H, Höög JO, Grafström RC,. 2007. Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma. J Proteome Res 6: 3705 - 3717.
108. Stutz H,. 2005. Advances in the analysis of proteins and peptides by capillary electrophoresis with matrix-assisted laser desorption/ionization and electrospray-mass spectrometry detection. Electrophoresis 26: 1254 - 1290.
109. Takes RP, Rinaldo A, Rodrigo JP, Devaney KO, Fagan JJ, Ferlito A,. 2008. Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer ? Head Neck 30: 525 - 538.
110. Tang J, Gao M, Deng C, Zhang X,. 2008. Recent development of multi-dimensional chromatography strategies in proteome research. J Chromatogr B Analyt Technol Biomed Life Sci 866: 123 - 132.
111. Turhani D, Krapfenbauer K, Thurnher D, Langen H, Fountoulakis M,. 2006. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27: 1417 - 1423.
112. Vuong GL, Weiss SM, Kammer W, Priemer M, Vingron M, Nordheim A, Cahill MA,. 2000. Improved sensitivity proteomics by postharvest alkylation and radioactive labelling of proteins. Electrophoresis 21: 2594 - 2605.
113. Wang Y, Balgley BM, Lee CS,. 2005. Tissue proteomics using capillary isoelectric focusing-based multidimensional separations. Expert Rev Proteomics 2: 659 - 667.
114. Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L, Chen P, Tong A, Tang M, Gao F, Shen J, Zhang Y, Bai J, Zhou M, Miao D, Chen Q,. 2008. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics 7: 1639 - 1650.
115. Warnakulasuriya S, Johnson NW, van der Waal I,. 2007. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36: 575 - 580.
116. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E,. 2008. Oral epithelial dysplasia classification systems: Predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37: 127 - 133.
117. Weng LP, Wu CC, Hsu BL, Chi LM, Liang Y, Tseng CP, Hsieh LL, Yu JS,. 2008. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J Proteome Res 7: 3765 - 3775.
118. Wilkins MR, Appel RD, Van Eyk JE, Chung MC, Görg A, Hecker M, Huber LA, Langen H, Link AJ, Paik YK, Patterson SD, Pennington SR, Rabilloud T, Simpson RJ, Weiss W, Dunn MJ,. 2006. Guidelines for the next 10 years of proteomics. Proteomics 6: 4 - 8.
119. Winiewski JR,. 2008. Mass spectrometry-based proteomics: Principles, perspectives, and challenges. Arch Pathol Lab Med 132: 1566 - 1569.
120. Wong DT,. 2006. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 137: 313 - 321.
121. Wouters BG,. 2008. Proteomics: Methodologies and applications in oncology. Semin Radiat Oncol 18: 115 - 125.
122. Wu J, Yan Y, Yan F, Ju H,. 2008. Electric field-driven strategy for multiplexed detection of protein biomarkers using a disposable reagentless electrochemical immunosensor array. Anal Chem 80: 6072 - 6077.
123. Yarbrough WG, Slebos RJ, Liebler D,. 2006. Proteomics: Clinical applications for head and neck squamous cell carcinoma. Head Neck 28: 549 - 558.
124. Ye H, Wang A, Lee BS, Yu T, Sheng S, Peng T, Hu S, Crowe DL, Zhou X,. 2008. Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Cancer Genomics Proteomics 5: 85 - 94.
125. Zieske LR,. 2006. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot 57: 1501 - 1508.
126. Zürbig P, Renfrow MB, Schiffer E, Novak J, Walden M, Wittke S, Just I, Pelzing M, Neusüss C, Theodorescu D, Root KE, Ross MM, Mischak H,. 2006. Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27: 2111 - 2125.